CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | ROBINS CHAD M CEO and Chairman | Gift | −100,000 | 2,080,518 | ||
| 2026-08-18 | ROBINS CHAD M CEO and Chairman | Option exercise | +278,676 | $6.55 | $1.8M | 2,459,194 |
| 2026-08-18 | ROBINS CHAD M CEO and Chairman | Sale | −278,472 | $24.48 | $6.8M | 2,180,722 |
| 2026-08-18 | ROBINS CHAD M CEO and Chairman | Sale | −204 | $25.14 | $5K | 2,180,518 |
| 2026-08-18 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (right to buy) | −278,676 | 0 | ||
| 2026-08-17 | ROBINS CHAD M CEO and Chairman | Option exercise | +321,324 | $6.55 | $2.1M | 2,501,842 |
| 2026-08-17 | ROBINS CHAD M CEO and Chairman | Sale | −318,799 | $25.08 | $8.0M | 2,183,043 |
| 2026-08-17 | ROBINS CHAD M CEO and Chairman | Sale | −2,525 | $25.57 | $65K | 2,180,518 |
| 2026-08-17 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (right to buy) | −321,324 | 278,676 | ||
| 2026-04-08 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −37,263 | $15.19 | $566K | 2,180,518 |
| 2026-04-06 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −83,332 | $14.41 | $1.2M | 2,217,781 |
| 2026-03-11 | ROBINS CHAD M CEO and Chairman | Sale | −140,567 | $13.17 | $1.9M | 2,630,713 |
| 2026-03-11 | ROBINS CHAD M CEO and Chairman | Sale | −329,600 | $13.17 | $4.3M | 2,301,113 |
| 2026-03-06 | ROBINS CHAD M CEO and Chairman | Grant or award | +709,220 | 2,771,280 | ||
| 2026-03-04 | ROBINS CHAD M CEO and Chairman | Grant or award | +127,813 | 2,062,060 | ||
| 2026-03-03 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −50,703 | $15.49 | $785K | 1,936,627 |
| 2026-03-03 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −2,380 | $16.15 | $38K | 1,934,247 |
| 2026-03-02 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −289,024 | $15.82 | $4.6M | 1,987,330 |
| 2026-02-27 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −182,891 | $15.99 | $2.9M | 2,276,354 |
| 2026-02-02 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −124,998 | $18.44 | $2.3M | 2,459,245 |
Page 1 of 14 · 274 trades